• Chinook Acquires Global Rights to Develop Atrasentan for Alport, Other Kidney Diseases
  • Gene Therapy Repairs Mutations in Kidney Cells from Alport Patients, Study Shows
  • US Kidney Disease Data Points to Need for Early Detection and Better Awareness, AKF Says
  • Reata and Invitae Partner to Offer Genetic Testing and Counseling for Chronic Kidney Disease
  • HHS Secretary Alex Azar Touts White House Efforts to Cure Rare Diseases
  • NY Kidney Recipient Becomes Spokesman for Alport Syndrome Foundation
  • Sangamo to Launch First-in-human Clinical Trial Testing TX200 Cell Therapy in End-stage Renal Disease
  • New COL4A4 Mutation Discovered in Young Boy With Alport Syndrome, Case Report Shows
  • Rare Disease Film Festival Highlights Patient and Researcher Unity
  • Bardoxolone May Improve Kidney Function in Alport Patients, Phase 3 Results Suggest
  • Investigational Cell Therapy FCR001 Shows Promise for Preventing Post-transplant Kidney Failure
  • Eye Deformity Common in Alport Best Captured Using Optical Coherence Tomography, Case Report Finds